Ipecac syrup abuse, morbidity, and mortality: Isn’t it time to repeal its over-the-counter status?
- 30 September 2005
- journal article
- research article
- Published by Elsevier in Journal of Adolescent Health
- Vol. 37 (3) , 256-260
- https://doi.org/10.1016/j.jadohealth.2004.08.022
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Ipecac Toxicity in "Munchausen Syndrome by Proxy"Therapeutic Drug Monitoring, 1999
- Pediatric ingestions: Charcoal alone versus ipecac and charcoalAnnals of Emergency Medicine, 1991
- Hemorrhagic Colitis and Pseudomelanosis Coli in Ipecac Ingestion by ProxyJournal of Pediatric Gastroenterology and Nutrition, 1991
- Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestionsAnnals of Emergency Medicine, 1989
- Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdoseAnnals of Emergency Medicine, 1987
- Efficacy of gastric emptying: Gastric lavage versus emesis induced with ipecacAnnals of Emergency Medicine, 1986
- Reversible Myopathy Secondary to Abuse of Ipecac in Patients with Major Eating DisordersNew England Journal of Medicine, 1985
- Activated Charcoal and Syrup of Ipecac in Prevention of Cimetidine and Pindolol Absorption in man after Administration of Metoclopramide as an Antiemetic AgentJournal of Toxicology: Clinical Toxicology, 1984
- Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdoseArchives of internal medicine (1960), 1984
- Mallory-Weiss syndrome: An unusual complication of ipecac-induced emesisAnnals of Emergency Medicine, 1981